Leucopenia in the First Year After Renal Transplantation During Valganciclovir Prophylaxis.

被引：0
|
作者：
Rissling, O. [1 ]
Naik, M. [1 ]
Brakemeier, S. [1 ]
Schmidt, D. [1 ]
Hohberger, A. [1 ]
Neumayer, H. [1 ]
Budde, K. [1 ]
机构：
[1] Charite CCM, Dept Nephrol, Berlin, Germany
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-02657
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
D2414
引用
收藏
页码：777 / 777
页数：1
相关论文
共 50 条
  • [41] An Evaluation of the Safety, Efficacy, and Pharmacoeconomics of Two Valganciclovir Prophylaxis Regimens Following Renal Transplantation
    Chen, J.
    Hoffman, R.
    Thomas, M.
    Gervasio, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 689 - 689
  • [42] GANCICLOVIR-VALGANCICLOVIR PROPHYLAXIS FOR 6 MONTHS AFTER LIVER TRANSPLANTATION IN CHILDREN
    Munoz Bartolo, Gema
    Hierro, Loreto
    Frauca, Esteban
    de la Vega, Angela
    Camarena, Carmen
    Diaz, Carmen
    Dolores Lledin, Maria
    Luis Encinas, Jose
    Hernandez, Francisco
    Leal, Nuria
    Murcia, Javier
    Gamez, Manuel
    Lopez Santamaria, Manuel
    Jara, Paloma
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 341 - 341
  • [43] Prevention of the hepatic artery thrombosis after liver transplantation using antiaggregant prophylaxis.
    Vivarelli, M
    Cuccetti, A
    La Barba, G
    Cescon, M
    Ercolani, G
    Lauro, A
    Varotti, G
    Grazi, GL
    Pinna, AD
    [J]. LIVER TRANSPLANTATION, 2006, 12 (05) : C32 - C32
  • [44] URINARY TRACT INFECTIONS DURING THE FIRST YEAR AFTER RENAL TRANSPLANTATION: SINGLE CENTER EXPERIENCE
    Kirnap, Mahir
    Akdur, Aydincan
    Moray, Gokhan
    Yildirim, Sedat
    Arslan, Hande
    Haberal, Mehmet
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 486 - 486
  • [45] Predictive factors for mycophenolic acid dose modification during the first year after renal transplantation
    Kamar, N
    Oufroukhi, L
    Faure, P
    Esposito, L
    Ribes, D
    Cointault, O
    Durand, D
    Rostaing, L
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V164 - V164
  • [46] GROWTH FOLLOW-UP IN CHILDREN DURING THE FIRST YEAR AFTER THE RENAL TRANSPLANTATION.
    Miteva, P.
    Roussinov, D.
    [J]. PEDIATRIC TRANSPLANTATION, 2017, 21 : 94 - 94
  • [47] Predictive factors for mycophenolic acid dose modification during the first year after renal transplantation
    Kamar, N
    Oufroukhi, L
    Esposito, L
    Cointault, O
    Ribes, D
    Durand, D
    Rostaing, L
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 323 - 323
  • [48] PROPHYLAXIS WITH VALGANCICLOVIR IN PEDIATRIC RENAL TRANSPLANTATION: DOES IT PREVENT FROM SEVERE EBV INFECTION?
    Roussey, G.
    Lagoutte, N.
    Ryckewaert, A.
    Novo, R.
    Harambat, J.
    [J]. PEDIATRIC TRANSPLANTATION, 2015, 19 : 126 - 126
  • [49] The 2VAL Study: Randomized Comparison of Valganciclovir Vs. Valacyclovir for Cytomegalovirus Prophylaxis after Renal Transplantation
    Reischig, T.
    Jindra, P.
    Hes, O.
    Lysak, D.
    Bouda, M.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 541 - 541
  • [50] Oral valganciclovir versus intravenous ganciclovir for CMV prophylaxis after lung transplantation
    Pierce, FN
    Nathan, SD
    Barnett, SD
    Schmidt, ME
    Ahmad, S
    Burton, NA
    [J]. CHEST, 2003, 124 (04) : 100S - 100S
12345